Address Development Challenges from Early Development Phase
Although many challenges arise once drugs are on the market, adherence has emerged as a major focus of scientists and developers. After all, improving the rate at which patients comply with dosing requirements could solve many other problems. It would, first and foremost, improve patient outcomes, which might in turn improve the competitive outlook for new drugs, as well as reimbursement scenarios. This eBook highlights how using novel technologies to more effectively deliver an existing drug can increase patient adherence while speeding up reformulation time & reducing costs.